Marc W. Hentz

Former Chief Executive Officer at Northern Bitcoin AG

Marc W. Hentz

Marc W. Hentz

Former Chief Executive Officer at Northern Bitcoin AG

Biography

Dr. Marc W. Hentz, MD, is Chief Executive Officer at amp biosimilars AG.Dr. Hentz was previously employed as a Managing Director by AMP-Therapeutics GmbH.He received his undergraduate degree from the University of Hamburg and a doctorate degree from the University of California San Diego.

Overview
Career Highlights

Northern Bitcoin AG

RelSci Relationships

26

Number of Boards

2

Relationships
RelSci Relationships are individuals Marc W. Hentz likely has professional access to. A relationship does not necessarily indicate a personal connection.

Managing Director at Taunus Trust GmbH

Relationship likelihood: Strong

Director, Key Competencies at Suomen Itsenäisyyden Juhlarahasto

Relationship likelihood: Strong

Former Director-Business Development at Aptanomics SA

Relationship likelihood: Strong

Founding Governor at The City Club of San Francisco, Inc.

Relationship likelihood: Strong

Former Co-Practice Group Leader, Board Consulting at Egon Zehnder International, Inc.

Relationship likelihood: Strong

Member, Advisory Board at Next Wave Funds

Relationship likelihood: Strong

Former Managing Director at AMP-Therapeutics GmbH

Relationship likelihood: Strong

Chief Executive Officer at Northern Bitcoin AG

Relationship likelihood: Strong

Former Director for Exploratory Research in Oncology, R&D Center at Boehringer Ingelheim GmbH

Relationship likelihood: Strong

Former Member, Advisory Board at Cenix BioScience GmbH

Relationship likelihood: Average

Paths to Marc W. Hentz
Potential Connections via
Relationship Science
You
Marc W. Hentz
Former Chief Executive Officer at Northern Bitcoin AG
Education

The University of California, San Diego (also referred to as UC San Diego or UCSD) is a public research university located in La Jolla, California, United States. Established in 1960 near the pre-existing Scripps Institution of Oceanography, UCSD is the seventh oldest of the 10 University of California campuses and offers over 200 undergraduate and graduate degree programs. UCSD is one of America's Public Ivy universities, which recognizes top public research universities in the United States.

The University of Hamburg is a comprehensive university in Hamburg, Germany. In spite of its relatively short history, six Nobel Prize Winners and serials of scholars are affiliated to the university. The University of Hamburg is the biggest research and education institution in Northern Germany and one of the most extensive universities in Germany. The main campus is located in the central district of Rotherbaum, with affiliated institutes and research centres spread around the city state.

Career History
Chief Executive Officer
Prior - 2016

Northern Bitcoin AG operates as a biopharmaceutical company which engages in the provision of life improving and life saving medications. It also offers biosimilar development and clinical research. The company was founded by Knut Adermann and is headquartered in Frankfurt, Germany.

Managing Director
2009 - 2015

AMP-Therapeutics GmbH operates as a pharmaceutical company. It discovers and develops medicines and antibiotics for the treatment of drug resistant infections. The company was founded by Ralf A. Hoffmann in 2009 and is headquartered in Leipzig, Germany.

Corporate Officer
2006 - 2007

Peppermint Holding GmbH operates as a holding company with interests in textile industries. Its company portfolios include Zwickauer Kammgarn, Ertex Jacquard, and Color Textil. The company was founded by Ingeborg Neumann in 1997 and is headquartered in Berlin, Germany.

Boards & Committees
Member, Advisory Board
Current
Chairman, Advisory Board
Prior

Cenix BioScience is a contract research organization specialized in combining advanced applications of RNAi with high content phenotypic analyses to enhance and accelerate the discovery and pre-clinical development of novel therapeutics. Cenix has built up a solid track record, successfully advancing therapeutic programs for numerous major industry and academic partners by addressing the specific needs of each through fully-customized, cutting-edge research offerings covering a wide range of disease fields. The well-established core capabilities in high throughput RNAi and multi-parametric microscopy assays have yielded optimized protocols in a broad and ever-growing collection of cultured cell models, and are now complemented by microRNA-focused experimentation and in vivo applications of synthetic siRNAs. As such, Cenix is a mature and fully-proven industrial research provider, applying the highest of scientific best practices and offering a breadth and depth of expertise second to none world wide

Investments
Details Hidden

AMP-Therapeutics GmbH operates as a pharmaceutical company. It discovers and develops medicines and antibiotics for the treatment of drug resistant infections. The company was founded by Ralf A. Hoffmann in 2009 and is headquartered in Leipzig, Germany.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Marc W. Hentz. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Marc W. Hentz's profile does not indicate a business or promotional relationship of any kind between RelSci and Marc W. Hentz.